Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib
Clinical trial NCT02636322 · COMPLETED
Trial details
- NCT number
- NCT02636322
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-29
- Primary completion
- 2022-10-24
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.